Shreya Bhandari and Hasmitha Kamineni 2021. Utilization of Intravenous (IV) Curcumin, Genistein, and Trastuzumab to Reduce HER2 receptors in Breast Cancer Patients. International Journal for Research in Applied Sciences and Biotechnology. 8, 4 (Jul. 2021), 104–109.